https://3dprintingindustry.com/news/cellink-and-carcinotech-partner-to-transform-cancer-drug-development-with-3d-bioprinting-225158/
CELLINK and Carcinotech partner to transform cancer drug development with 3D bioprinting - 3D...
Oct 9, 2023 - Carcinotech and 3D bioprinting firm CELLINK have announced a partnership to accelerate cancer drug development with 3D bioprinted tumor models. The partnership...
cancer drug development
https://www.foxbusiness.com/markets/takeda-and-crescendo-biologics-enter-into-cancer-drug-development-partnership
Takeda And Crescendo Biologics Enter Into Cancer Drug Development Partnership | Fox Business
Takeda Pharmaceutical Company Limited and Crescendo Biologics Limited said early Monday they entered into a cancer drug development partnership worth up to $36...
cancer drug developmententer into
https://www.dkfz.de/en/cancer-drug-development
Cancer Drug Development - German Cancer Research Center
The Cancer Drug Development Group discovers and develops small molecules precisely tailored to inhibit specific oncogenic proteins and target individual...
cancer drug developmentgerman researchcenter
https://cancer.unitedscientificgroup.org/
CRD 2026 | Cancer Conferences | Cancer Research & Drug Development Conferences
CRD 2026 (Cancer Research and Development) Conference is a three-day congress dedicated to basic, preclinical, and translational cancer research across a wide...
crd2026cancerconferencesresearch